ChemImpex Ozagrel hydrochloride hydrate; 98% (Assay, HPLC); 78712-43-3; MFCD06795644, 5G

Ozagrel hydrochloride hydrate is a potent compound recognized for its role as a selective inhibitor of thromboxane A2 synthase, making it a valuable asset in the field of cardiovascular research and treatment. This compound is particularly significant in the management of thrombotic disorders, as it effectively reduces platelet aggregation and improves blood flow. Its unique structure, featuring an imidazole moiety, enhances its bioactivity, allowing for targeted therapeutic applications. Researchers have utilized Ozagrel hydrochloride hydrate in various studies to explore its efficacy in preventing ischemic events, showcasing its potential in both acute and chronic cardiovascular conditions.

In addition to its cardiovascular applications, Ozagrel hydrochloride hydrate has been investigated for its neuroprotective properties, offering promising avenues for treating neurodegenerative diseases. Its ability to modulate inflammatory responses further underscores its versatility in therapeutic contexts. With a favorable safety profile and a mechanism of action that distinguishes it from other antithrombotic agents, Ozagrel hydrochloride hydrate stands out as a compelling choice for researchers and healthcare professionals seeking innovative solutions in the management of thrombotic and inflammatory conditions.

Specifications

Safety & Regulations